Valsartan vs. Olmesartan: What's the Difference?
Valsartan and olmesartan are both angiotensin II receptor blockers (ARBs) used to treat high blood pressure and heart failure [1][2]. While they share a similar mechanism of action, there are differences in their molecular structure, approved indications, and potential side effects [3][4].
How Do These Blood Pressure Medications Work?
Both valsartan and olmesartan function by blocking the action of angiotensin II, a hormone that narrows blood vessels [2][5]. By preventing this narrowing, the blood vessels relax, leading to lower blood pressure [2][5]. This also reduces the workload on the heart [2][5].
What Are the Specific Uses for Valsartan and Olmesartan?
Valsartan is approved for treating high blood pressure in adults and children aged 1 to 16 years, heart failure in adults, and to reduce cardiovascular events in certain patients after a heart attack [3]. Olmesartan is approved for treating high blood pressure in adults and children aged 6 to 16 years [4].
Are There Any Differences in Their Side Effects?
While many side effects are common to both ARBs, such as dizziness, fatigue, and kidney problems, some specific concerns exist. A rare but serious side effect associated with olmesartan is sprue-like enteropathy, which causes severe chronic diarrhea and significant weight loss [4][6]. This condition can occur months or even years after starting the medication [6]. Valsartan has also faced recalls due to the presence of nitrosamine impurities, although these issues have largely been addressed [7].
When Do the Patents for Valsartan and Olmesartan Expire?
Drug patent expiration dates are crucial for the introduction of generic versions, which can significantly lower medication costs. Information on specific patent expirations for valsartan and olmesartan can be found on resources like DrugPatentWatch.com [8]. The original patent for valsartan has expired, allowing for generic versions to be available [7]. Similarly, olmesartan also has generic alternatives on the market following patent expirations [9].
What Are the Alternatives to Valsartan and Olmesartan?
Besides each other, other ARBs are available, including losartan, candesartan, irbesartan, telmisartan, and azilsartan [5]. Other classes of blood pressure medications also exist, such as ACE inhibitors, calcium channel blockers, and diuretics, which may be used alone or in combination with ARBs depending on a patient's specific needs and medical history [10].
Sources:
1. https://www.drugpatentwatch.com/
2. National Institutes of Health. "Angiotensin II Receptor Blockers (ARBs)." MedlinePlus.
3. Lupin Pharmaceuticals, Inc. "Valsartan Tablets USP." DailyMed.
4. AstraZeneca Pharmaceuticals LP. "Olmesartan Medoxomil Tablets." DailyMed.
5. U.S. Food & Drug Administration. "Angiotensin II Receptor Blockers (ARBs)." FDA.gov.
6. Siddiq, Muhammad A., et al. "Olmesartan-Induced Sprue-Like Enteropathy: A Case Report and Literature Review." Cureus, vol. 12, no. 1, 2020, p. e6558.
7. U.S. Food & Drug Administration. "FDA Investigating Nitrosamine Impurities in Valsartan Products." FDA.gov.
8. DrugPatentWatch.com.
9. https://www.drugs.com/availability/olmesartan-medoxomil.html
10. Mayo Clinic. "High blood pressure (hypertension)." MayoClinic.org.